Adam Urato: Understanding SSRI Impacts on Maternal and Fetal Serotonin Levels
Adam Urato, Maternal-Fetal Medicine Physician at MetroWest Medical Center, shared a post on X about a recent article by Amy L. Salisbury et al., published in Neuropsychopharmacology, adding:
“Remember, SSRIs have a profound chemical impact on a pregnant mom and her baby.
Platelet serotonin levels are dramatically lower for both and it’s likely there are similar effects in the brain, since SSRIs block the serotonin transporter (present in the brain and platelets).”
Title: Fetal behavior and gestational serotonin reuptake inhibitor exposure: relationships between behavior, drug dosage, plasma drug level, and a measure of drug bioeffect
Authors: Amy L. Salisbury, George M. Anderson, Amy Yang, Catherine S. Stika, Laura J. Rasmussen-Torvik, Jacqueline K. Gollan, Katherine L. Wisner
Stay updated with Hemostasis Today.
-
Oct 3, 2026, 12:02Cedric Hermans: How Should We Define Success in Haemophilia Care beyond Bleeding Rates?
-
Oct 3, 2026, 08:31Víctor S. Rangel: Advanced Endovascular Management in Severe Postpartum CVST
-
Oct 3, 2026, 08:05Are Circadian Rhythms Fueling Thrombotic Risk in Space? – RPTH Journal
-
Oct 3, 2026, 07:43Janez Urevc: Modeling Compression Ultrasound for Internal Jugular Vein Thrombosis in Astronauts
-
Oct 3, 2026, 07:20Adam Wufsus: Novo Nordisk Seeks Medical Liaison for Sickle Cell Disease
-
Oct 3, 2026, 07:16Álvaro Dubois-Silva: Rethinking the Obesity Paradox in Cancer-Associated VTE
-
Oct 3, 2026, 07:09Lori Bryngelson Taylor: Expert Consensus Guidelines Flag Hypophosphatemia Risks With Injectafer
-
Oct 3, 2026, 06:40Aayush Bist: Study Reveals Distinct Social Patterns in Anemia, Excess Adiposity, and High Blood Pressure Among Women in Nepal
-
Oct 3, 2026, 06:39Ahmed Bennis: Understanding the Diagnosis, Risk, and Management of ARN